Performance comparison of three commercial tests for the detection of SARS-CoV-2 antibodies in a common set of pediatric samples

CONCLUSIONS: Our findings suggest good performance of commercial SARS-CoV-2 IgG assays in pediatric patients with samples collected ≥15 days PSO. Additional studies investigating antibody response and assay performance in children are warranted.PMID:37567470 | DOI:10.1016/j.jim.2023.113536
Source: Journal of Immunological Methods - Category: Allergy & Immunology Authors: Source Type: research